154 related articles for article (PubMed ID: 34275401)
1. Real-world changes in US health system hospital-based services following treatment with a prescription digital therapeutic for opioid use disorder.
Velez FF; Colman S; Kauffman L; Anastassopoulos K; Murphy S; Maricich Y
Hosp Pract (1995); 2021 Dec; 49(5):341-347. PubMed ID: 34275401
[TBL] [Abstract][Full Text] [Related]
2. Real-world reduction in healthcare resource utilization following treatment of opioid use disorder with reSET-O, a novel prescription digital therapeutic.
Velez FF; Colman S; Kauffman L; Ruetsch C; Anastassopoulos K
Expert Rev Pharmacoecon Outcomes Res; 2021 Feb; 21(1):69-76. PubMed ID: 33146558
[TBL] [Abstract][Full Text] [Related]
3. Real-world use and clinical outcomes after 24 weeks of treatment with a prescription digital therapeutic for opioid use disorder.
Maricich YA; Gerwien R; Kuo A; Malone DC; Velez FF
Hosp Pract (1995); 2021 Dec; 49(5):348-355. PubMed ID: 34461801
[TBL] [Abstract][Full Text] [Related]
4. Reduced Healthcare Resource Utilization in Patients with Opioid Use Disorder in the 12 Months After Initiation of a Prescription Digital Therapeutic.
Velez FF; Anastassopoulos KP; Colman S; Shah N; Kauffman L; Murphy SM; Ruetsch C; Maricich YA
Adv Ther; 2022 Sep; 39(9):4131-4145. PubMed ID: 35799080
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Healthcare Resource Utilization Between Patients Who Engaged or Did Not Engage With a Prescription Digital Therapeutic for Opioid Use Disorder.
Velez FF; Colman S; Kauffman L; Ruetsch C; Anastassopoulos K; Maricich YA
Clinicoecon Outcomes Res; 2021; 13():909-916. PubMed ID: 34754205
[TBL] [Abstract][Full Text] [Related]
6. Opioid drug utilization and cost outcomes associated with the use of buprenorphine-naloxone in patients with a history of prescription opioid use.
Kaur AD; McQueen A; Jan S
J Manag Care Pharm; 2008 Mar; 14(2):186-94. PubMed ID: 18331120
[TBL] [Abstract][Full Text] [Related]
7. Real-world evidence for a prescription digital therapeutic to treat opioid use disorder.
Maricich YA; Xiong X; Gerwien R; Kuo A; Velez F; Imbert B; Boyer K; Luderer HF; Braun S; Williams K
Curr Med Res Opin; 2021 Feb; 37(2):175-183. PubMed ID: 33140981
[TBL] [Abstract][Full Text] [Related]
8. Economic modeling of reSET-O, a prescription digital therapeutic for patients with opioid use disorder.
Wang W; Gellings Lowe N; Jalali A; Murphy SM
J Med Econ; 2021; 24(1):61-68. PubMed ID: 33267633
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the cost-utility of a prescription digital therapeutic for the treatment of opioid use disorder.
Velez FF; Luderer HF; Gerwien R; Parcher B; Mezzio D; Malone DC
Postgrad Med; 2021 May; 133(4):421-427. PubMed ID: 33593201
[No Abstract] [Full Text] [Related]
10. Cost-effectiveness of Treatments for Opioid Use Disorder.
Fairley M; Humphreys K; Joyce VR; Bounthavong M; Trafton J; Combs A; Oliva EM; Goldhaber-Fiebert JD; Asch SM; Brandeau ML; Owens DK
JAMA Psychiatry; 2021 Jul; 78(7):767-777. PubMed ID: 33787832
[TBL] [Abstract][Full Text] [Related]
11. A Prescription Digital Therapeutic to Support Unsupervised Buprenorphine Initiation for Patients With Opioid Use Disorder: Protocol for a Proof-of-Concept Study.
Luderer H; Enman N; Gerwien R; Braun S; McStocker S; Xiong X; Koebele C; Cannon C; Glass J; Maricich Y
JMIR Res Protoc; 2023 Jan; 12():e43122. PubMed ID: 36662568
[TBL] [Abstract][Full Text] [Related]
12. Variation in Initiation, Engagement, and Retention on Medications for Opioid Use Disorder Based on Health Insurance Plan Design.
Morgan JR; Quinn EK; Chaisson CE; Ciemins E; Stempniewicz N; White LF; Linas BP; Walley AY; LaRochelle MR
Med Care; 2022 Mar; 60(3):256-263. PubMed ID: 35026792
[TBL] [Abstract][Full Text] [Related]
13. Five-year budget impact of a prescription digital therapeutic for patients with opioid use disorder.
Velez FF; Huang D; Mody L; Malone DC
Expert Rev Pharmacoecon Outcomes Res; 2022 Jun; 22(4):599-607. PubMed ID: 34894988
[TBL] [Abstract][Full Text] [Related]
14. Association Between Hospital Adoption of an Emergency Department Treatment Pathway for Opioid Use Disorder and Patient Initiation of Buprenorphine After Discharge.
Solomon KT; O'Connor J; Gibbons JB; Kilaru AS; Feder KA; Xue L; Saloner B; Stuart EA; Cole ES; Hulsey E; Meisel Z; Patel E; Donohue JM
JAMA Health Forum; 2023 Mar; 4(3):e230245. PubMed ID: 36961457
[TBL] [Abstract][Full Text] [Related]
15. Opioid use disorder in Germany: healthcare costs of patients in opioid maintenance treatment.
Reimer J; Vogelmann T; Trümper D; Scherbaum N
Subst Abuse Treat Prev Policy; 2019 Dec; 14(1):57. PubMed ID: 31842942
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary care.
Schackman BR; Leff JA; Polsky D; Moore BA; Fiellin DA
J Gen Intern Med; 2012 Jun; 27(6):669-76. PubMed ID: 22215271
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness Analysis of a Prescription Digital Therapeutic for the Treatment of Opioid Use Disorder.
Velez FF; Malone DC
J Mark Access Health Policy; 2021; 9(1):1966187. PubMed ID: 34434535
[TBL] [Abstract][Full Text] [Related]
18. Real-World Reductions in Healthcare Resource Utilization over 6 Months in Patients with Substance Use Disorders Treated with a Prescription Digital Therapeutic.
Shah N; Velez FF; Colman S; Kauffman L; Ruetsch C; Anastassopoulos K; Maricich Y
Adv Ther; 2022 Sep; 39(9):4146-4156. PubMed ID: 35819569
[TBL] [Abstract][Full Text] [Related]
19. Healthcare utilization and costs associated with treatment for opioid dependence.
Shah A; Duncan M; Atreja N; Tai KS; Gore M
J Med Econ; 2018 Apr; 21(4):406-415. PubMed ID: 29320915
[TBL] [Abstract][Full Text] [Related]
20. Patient Engagement With a Game-Based Digital Therapeutic for the Treatment of Opioid Use Disorder: Protocol for a Randomized Controlled Open-Label, Decentralized Trial.
Luderer H; Chiodo L; Wilson A; Brezing C; Martinez S; Xiong X; Gerwien R; Imbert B; Deeg M; Maricich Y; Campbell A
JMIR Res Protoc; 2022 Jan; 11(1):e32759. PubMed ID: 35080499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
